...
首页> 外文期刊>Journal of Korean medical science >Genetic analysis of dystrophin gene for affected male and female carriers with Duchenne/Becker muscular dystrophy in Korea
【24h】

Genetic analysis of dystrophin gene for affected male and female carriers with Duchenne/Becker muscular dystrophy in Korea

机译:韩国Duchenne / Becker肌营养不良症患病男性和女性携带者肌营养不良蛋白基因的遗传分析

获取原文
获取原文并翻译 | 示例
           

摘要

Duchenne and Becker muscular dystrophy (DMD/BMD) are X-linked recessive disorders caused by mutation in dystrophin gene. We analyzed the results of a genetic test in 29 DMD/BMD patients, their six female relatives, and two myopathic female patients in Korea. As the methods developed, we applied different procedures for dystrophin gene analysis; initially, multiplex polymerase chain reaction was used, followed by multiplex ligation-dependent probe amplification (MLPA). Additionally, we used direct DNA sequencing for some patients who had negative results using the above methods. The overall mutation detection rate was 72.4% (21/29) in DMD/BMD patients, identifying deletions in 58.6% (17/29). Most of the deletions were confined to the central hot spot region between exons 44 and 55 (52.9%, 7/19). The percentage of deletions and duplications revealed by MLPA was 45.5% (5/11) and 27.2% (3/11), respectively. Using the MLPA method, we detected mutations confirming their carrier status in all female relatives and symptomatic female patients. In one patient in whom MLPA revealed a single exon deletion of the dystrophin gene, subsequent DNA sequencing analysis identified a novel nonsense mutation (c.4558G > T; Gln1520X). The MLPA assay is a useful quantitative method for detecting mutation in asymptomatic or symptomatic carriers as well as DMD/BMD patients.
机译:Duchenne和Becker肌肉营养不良(DMD / BMD)是X连锁隐性疾病,由肌营养不良蛋白基因突变引起。我们分析了韩国29位DMD / BMD患者,其6名女性亲属和2名肌病女性患者的基因测试结果。随着方法的发展,我们对肌营养不良蛋白基因分析应用了不同的程序。最初,使用多重聚合酶链反应,然后进行多重连接依赖性探针扩增(MLPA)。此外,我们对使用上述方法获得阴性结果的某些患者进行了直接DNA测序。 DMD / BMD患者的总体突变检出率为72.4%(21/29),发现缺失的占58.6%(17/29)。大多数缺失被限制在外显子44和55之间的中心热点区域(52.9%,7/19)。 MLPA揭示的删除和重复百分比分别为45.5%(5/11)和27.2%(3/11)。使用MLPA方法,我们在所有女性亲属和有症状女性患者中检测到证实其携带者状态的突变。在一名MLPA揭示了肌营养不良蛋白基因的单个外显子缺失的患者中,随后的DNA测序分析确定了一个新的无意义突变(c.4558G> T; Gln1520X)。 MLPA测定法是检测无症状或有症状携带者以及DMD / BMD患者突变的有用的定量方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号